Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma – the GlioCave study (NOA 17 – ARO 2016/3 – DKTK ROG trial)

被引:0
作者
Christoph Straube
Hagen Scherb
Jens Gempt
Jan Kirschke
Claus Zimmer
Friederike Schmidt-Graf
Bernhard Meyer
Stephanie E. Combs
机构
[1] Technische Universität München (TUM),Klinik für RadioOnkologie und Strahlentherapie
[2] Helmholtz Zentrum München,Institute of Computational Biology
[3] Deutsches Forschungszentrum fuer Gesundheit und Umwelt (GmbH),Neurochirurgische Klinik und Poliklinik
[4] Technische Universität München (TUM),Abteilung für diagnostische und interventionelle Neuroradiologie
[5] Technische Universität München (TUM),Neurologische Klinik und Poliklinik
[6] Technische Universität München (TUM),Institut für Innovative Radiotherapie (iRT), Department of Radiation Sciences (DRS)
[7] Helmholtz Zentrum München,undefined
[8] Deutsches Konsortium für Translationale Krebsforschung (DKTK) - Partner Site Munich,undefined
来源
BMC Cancer | / 18卷
关键词
Glioblastoma; Recurrence; Re-irradiation; Gross total resection; Randomized trial; NOA; PFS;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 292 条
[1]  
DeAngelis LM(2001)Brain tumors N Engl J Med 344 114-123
[2]  
Combs S(2016)Stress response leading to resistance in Glioblastoma—the need for innovative radiotherapy (iRT) concepts Cancers 8 15-996
[3]  
Schmid T(2005)Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987-722
[4]  
Vaupel P(2014)Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma N Engl J Med 370 709-148
[5]  
Multhoff G(2011)Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme J Clin Oncol 29 142-578
[6]  
Stupp R(2014)Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: north American brain tumor consortium trial 04-02 Neuro-Oncology 16 567-1211
[7]  
Mason WP(2013)RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients Int. J. Radiat. Oncol. Biol. Phys. 85 1206-221
[8]  
van den Bent MJ(2012)Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study Neuro-Oncology 14 215-727
[9]  
Weller M(1994)Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost Int J Radiat Oncol Biol Phys 29 719-27
[10]  
Fisher B(2013)Standards of care for treatment of recurrent glioblastoma-are we there yet? Neuro-Oncology 15 4-14